Latest Press Releases

1000 Miglia 2025, Vesco-Salvinelli six times champions in a 1929 Alfa Romeo 6c 1750 Ss

BRESCIA, Italy, June 23, 2025 (GLOBE NEWSWIRE) -- After 5 racing days , 1900 kilometres and over 400 classic cars in movement, today the forty-third re-enactment of the 1000 Miglia ended in Brescia . A special edition, bringing back to ...

From Ancestry Entertainment to Real Health: Why 23andMe Failed and HoliVita Delivers

A significant change is underway in the field of personal genomic testing, as early leaders like 23andMe, AncestryDNA, or MyHeritage are losing their relevance due to the minimal to no practical value of their offerings and a rather ...

Are You Eligible for a Government Health Scheme? A Checklist You Can Use Today

Health care can be very expensive. However, several health schemes are run by the government to cater to the health needs of those who cannot afford private treatment. These schemes provide free or nearly free healthcare to those who qualify for ...

Smith+Nephew and Standard Health partner on first Orthopaedic Ambulatory Surgery Centre in the UK

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces a strategic partnership with Standard Health www.standardhealth.co.uk to support the development of the first-ever Orthopaedic Ambulatory Surgery Centre in ...

Sephience™ (sepiapterin) Granted Marketing Authorization by the European Commission for the Treatment of Children and Adults Living with Phenylketonuria (PKU)

PR Newswire WARREN, N.J., June 23, 2025 – Broad label inclusive of all ages and disease severities – – Launch to be initiated in Germany – WARREN, N.J., June 23, 2025 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today ...

Leap Therapeutics Reports Updated Clinical Data from Sirexatamab Colorectal Cancer Study and Announces Exploration of Strategic Alternatives

PR Newswire CAMBRIDGE, Mass., June 23, 2025 Updated data from DeFianCe study continue to demonstrate statistically significant improvements in PFS among the DKK1-high, VEGF-naïve and liver metastasis subgroups Board of Directors has ...

Loma Linda University Health study shows vegetarian diets have reduced risk of medium-frequency cancers

PR Newswire LOMA LINDA, Calif., June 23, 2025 Researchers found that a vegetarian diet was associated with even greater risk reduction of stomach cancer, as high as 45%, as well as lymphomas by 25%. This is the first study with strong ...

Kanazawa University research: From hydration layers to nanoarchitectures: Water's pivotal role in peptide organization on 2D nanomaterials

PR Newswire KANAZAWA, Japan, June 23, 2025 KANAZAWA, Japan, June 23, 2025 /PRNewswire/ -- Researchers at the Nano Life Science Institute (WPI-NanoLSI), Kanazawa University, report in Small, a weekly peer-reviewed scientific journal covering ...

Cell Study by SDU and PKU Researchers Reveals Novel Mechanism to Regulate Glucose Metabolism

PR Newswire JINAN, China, June 23, 2025 JINAN, China, June 23, 2025 /PRNewswire/ -- On May 29, 2025, Professor Sun Jinpeng's team and Professor Yu Xiao's team at Shandong University, collaborating with Professor Jiang Changtao from Peking ...

IASO Bio presents promising efficacy of Equecabtagene Autoleucel in patients with Multiple Sclerosis in IIT study at the 11th Congress of the European Academy of Neurology (EAN)

PR Newswire SHANGHAI and NANJING, China and SAN FRANCISCO, June 22, 2025 SHANGHAI and NANJING, China and SAN FRANCISCO, June 22, 2025 /PRNewswire/ -- IASO Biotherapeutics ("IASO Bio"), a biopharmaceutical company focused on the discovery, ...

EAN Congress: Frequent nightmares triple risk of early death and accelerate ageing, major study finds

PR Newswire HELSINKI, June 23, 2025 HELSINKI, June 23, 2025 /PRNewswire/ -- New research presented today at the European Academy of Neurology (EAN) Congress 2025 reveals that frequent nightmares are associated with significantly accelerated ...

Oral Semaglutide Significantly Improves Cardiovascular Outcomes in Individuals with Type 2 Diabetes

PR Newswire CHICAGO, June 22, 2025 Oral formulation demonstrates comparable cardiovascular benefits to injectable GLP-1s CHICAGO, June 22, 2025 /PRNewswire/ -- A recent study found that oral semaglutide offers meaningful cardiovascular ...

Mim8 prophylaxis treatment shown to be well-tolerated when switching from emicizumab in people with hemophilia A in new phase 3 data presented at the ISTH 2025 Congress

PR Newswire PLAINSBORO, N.J., June 22, 2025 PLAINSBORO, N.J., June 22, 2025 /PRNewswire/ -- Novo Nordisk today presented results from the phase 3b FRONTIER5 trial showing that a direct switch to investigational Mim8 (denecimig) prophylaxis ...

Revolutionary Research by Dr. Takuma Hayashi Uncovers Molecular Origins of Deadly Uterine Cancer and Charts New Path for Treatment

PR Newswire MATSUMOTO, Japan, June 22, 2025 In a landmark advancement for women's cancer research, Dr. Takuma Hayashi and his team have made groundbreaking discoveries that could transform our understanding and treatment of uterine ...

Once-Weekly Insulin Efsitora Achieves Comparable A1C Reduction to Daily Insulin Therapy

PR Newswire CHICAGO, June 22, 2025 Once-weekly insulin helped patients achieve an average A1C of 6.92% in QWINT-1 trial Results support once-weekly insulin as effective alternative to daily treatment CHICAGO, June 22, 2025 ...

Inhaled Insulin Shown as a Safe and Effective Replacement for Standard-of-Care in Children with Type 1 Diabetes

PR Newswire CHICAGO, June 22, 2025 Findings Highlight Potential for Novel Approach to Insulin Delivery in Pediatric Population CHICAGO, June 22, 2025 /PRNewswire/ -- Today, a new study demonstrates inhaled insulin as a safe and effective ...

CagriSema Demonstrates Significant Weight Loss in Adults with Obesity

PR Newswire CHICAGO, June 22, 2025 Once-weekly medication results in weight loss of up to 22.7% in adults without diabetes and 15.7% in those with type 2 diabetes CHICAGO, June 22, 2025 /PRNewswire/ -- Findings from two studies ...

The American Diabetes Association Announces Winners of the Innovation Challenge to Transform Diabetes Care

PR Newswire CHICAGO, June 21, 2025 This challenge Kickstarts additional investments through the new ADA Innovation Fund CHICAGO, June 21, 2025 /PRNewswire/ -- As the American Diabetes Association® (ADA) celebrates its 85th anniversary, ...

Semaglutide Increases Walking Capacity in Patients with Peripheral Artery Disease and Type 2 Diabetes

PR Newswire CHICAGO, June 21, 2025 Common obesity drug reduced the risk of disease progression by 54% CHICAGO, June 21, 2025 /PRNewswire/ -- Today, a new analysis demonstrates the vascular benefits of semaglutide in patients with ...

Biomarkers and New Therapeutic Strategies to Better Treat Brain Cancer

Canada NewsWire LAVAL, QC, June 20, 2025 INRS Professor receives $1.2M to advance glioblastoma research LAVAL, QC, June 20, 2025 /CNW/ - Professor Maya Saleh, a world-renowned expert in immuno-oncology at the Institut national de la ...

HER2-low Cancers Market Set to Register Immense Growth at a CAGR of 9.4% During the Study Period (2020-2034) | DelveInsight

PR Newswire LAS VEGAS, June 19, 2025 The future of the HER2-low cancer treatment market is poised for significant transformation, driven by the approval of ENHERTU and the advancement of other innovative antibody-drug conjugates (ADCs) like ...

New Study Data on Chemo-Immunotherapy Approach Using the ELIAS Cancer Immunotherapy (ECI®) to Treat Bone Cancer in Dogs Demonstrates Improved Outcomes

PR Newswire LENEXA, Kan., June 19, 2025 LENEXA, Kan., June 19, 2025 /PRNewswire/ -- ELIAS Animal Health, a leading companion animal cancer therapeutics company, today announced interim results from an ongoing clinical study evaluating ELIAS ...

RWJBarnabas Health, Rutgers Cancer Institute, Tufts Medical Center, and The University of Manchester Develop First Risk Prediction Model for Early-Stage Classic Hodgkin's Lymphoma

PR Newswire NEW BRUNSWICK, N.J. and BOSTON, June 19, 2025 Research Published in NEJM Evidence and presented at the International Conference on Malignant Lymphoma NEW BRUNSWICK, N.J. and BOSTON, June 19, 2025 /PRNewswire/ -- Researchers ...

Zemcelpro® (UM171 Cell Therapy) receives positive CHMP opinion for treatment of blood cancer patients without access to suitable donor cells

PR Newswire MONTREAL, June 19, 2025 MONTREAL, June 19, 2025 /PRNewswire/ - ExCellThera Inc. (ExCellThera), a world leader in blood stem cell expansion and metabolic fitness, announced today the Committee for Medicinal Products for Human Use ...

Japan's Top Eczema App, Atopiyo, Launches in the US: Pioneering Digital Eczema Care

PR Newswire CHIBA, Japan, June 19, 2025 11-time award winner, university-backed, delivers what 31M patients need most — visual tracking, peer support, AI analysis CHIBA, Japan, June 19, 2025 /PRNewswire/ -- Living with eczema isn't just ...

Dizal Completes Enrollment for its Phase III Pivotal Study of Sunvozertinib vs. Platinum Doublet in Treatment Naïve NSCLC Patients with EGFR Exon20 Insertional Mutations

PR Newswire SHANGHAI, June 19, 2025 SHANGHAI, June 19, 2025 /PRNewswire/ -- Dizal announced the completion of patient enrollment for its WU-KONG28 clinical trial: a multinational, randomized phase III study evaluating the efficacy and safety ...

Immuno Cure and PharmaJet Announce Collaboration to Advance a Novel HIV Therapeutic DNA Vaccine Using Needle-Free Technology in Humans

PR Newswire HONG KONG, June 19, 2025 HONG KONG, June 19, 2025 /PRNewswire/ -- Immuno Cure BioTech ("Immuno Cure"), a clinical-stage biotechnology group based in Hong Kong Science Park, is pleased to announce its upcoming collaboration with ...

Simcere Zaiming Announces First Patient Dosed in the US in a Phase 1 Trial of Trispecific Antibody SIM0500 in Patients with Relapsed/Refractory Multiple Myeloma

PR Newswire SHANGHAI, June 18, 2025 SHANGHAI, June 18, 2025 /PRNewswire/ -- Simcere Zaiming, an innovative oncology-focused subsidiary of Simcere Pharmaceutical Group (2096.HK) today announced the first US patient has started treatment in ...

Osteoarthritis Market is Predicted to Exhibit Remarkable Growth During the Forecast Period (2025-2034) | DelveInsight

PR Newswire LAS VEGAS, June 18, 2025 According to DelveInsight's analysis, the current developmental pipeline for osteoarthritis is robust, with several companies initiating clinical trials to investigate new treatment options or improve the ...

From Ancestry Entertainment to Real Health: Why 23andMe Failed and HoliVita Delivers

A significant change is underway in the field of personal genomic testing, as early leaders like 23andMe, AncestryDNA, or MyHeritage are losing their relevance due to the minimal to no practical value of their offerings and a rather ...

Are You Eligible for a Government Health Scheme? A Checklist You Can Use Today

Health care can be very expensive. However, several health schemes are run by the government to cater to the health needs of those who cannot afford private treatment. These schemes provide free or nearly free healthcare to those who qualify for ...

Camurus' POSITANO study shows treatment effects with CAM2029 in polycystic liver disease patients

PR Newswire LUND, Sweden, June 18, 2025 LUND, Sweden, June 18, 2025 /PRNewswire/ -- Camurus (NASDAQ STO: CAMX) today announced topline results from the 12-month, randomized, double-blind, placebo-controlled POSITANO Phase 2b study ...

Oncoinvent Announces Positive Final Data from Phase 1/2a Trial of Radspherin® in Patients with Colorectal Peritoneal Metastases

PR Newswire OSLO, Norway, June 18, 2025 Data demonstrate sustained peritoneal disease control and reinforce the potential of Oncoinvent's novel radiopharmaceutical therapy to target peritoneal disease in colorectal cancer OSLO, Norway, ...

Ascletis Announces First Participants Dosed in U.S. Phase I Clinical Study of ASC50, a Potential Best-in-Class Oral Small Molecule IL-17 Inhibitor for the Treatment of Psoriasis

PR Newswire HONG KONG, June 17, 2025 - The Phase I trial evaluates the safety, tolerability and preliminary efficacy of ASC50 for the treatment of psoriasis.- Preclinical data, including higher oral exposure, longer half-life and strong ...

Latest Press Releases

Premium Press Releases »

1000 Miglia 2025, Vesco-Salvinelli six times champions in a 1929 Alfa Romeo 6c 1750 Ss

From Ancestry Entertainment to Real Health: Why 23andMe Failed and HoliVita Delivers

Are You Eligible for a Government Health Scheme? A Checklist You Can Use Today

Smith+Nephew and Standard Health partner on first Orthopaedic Ambulatory Surgery Centre in the UK

Press Releases »

Sephience™ (sepiapterin) Granted Marketing Authorization by the European Commission for the Treatment of Children and Adults Living with Phenylketonuria (PKU)

Leap Therapeutics Reports Updated Clinical Data from Sirexatamab Colorectal Cancer Study and Announces Exploration of Strategic Alternatives

Loma Linda University Health study shows vegetarian diets have reduced risk of medium-frequency cancers

Kanazawa University research: From hydration layers to nanoarchitectures: Water's pivotal role in peptide organization on 2D nanomaterials

Cell Study by SDU and PKU Researchers Reveals Novel Mechanism to Regulate Glucose Metabolism

IASO Bio presents promising efficacy of Equecabtagene Autoleucel in patients with Multiple Sclerosis in IIT study at the 11th Congress of the European Academy of Neurology (EAN)

EAN Congress: Frequent nightmares triple risk of early death and accelerate ageing, major study finds

Oral Semaglutide Significantly Improves Cardiovascular Outcomes in Individuals with Type 2 Diabetes

Mim8 prophylaxis treatment shown to be well-tolerated when switching from emicizumab in people with hemophilia A in new phase 3 data presented at the ISTH 2025 Congress

Revolutionary Research by Dr. Takuma Hayashi Uncovers Molecular Origins of Deadly Uterine Cancer and Charts New Path for Treatment

Once-Weekly Insulin Efsitora Achieves Comparable A1C Reduction to Daily Insulin Therapy

Inhaled Insulin Shown as a Safe and Effective Replacement for Standard-of-Care in Children with Type 1 Diabetes

CagriSema Demonstrates Significant Weight Loss in Adults with Obesity

The American Diabetes Association Announces Winners of the Innovation Challenge to Transform Diabetes Care

Semaglutide Increases Walking Capacity in Patients with Peripheral Artery Disease and Type 2 Diabetes

Biomarkers and New Therapeutic Strategies to Better Treat Brain Cancer

HER2-low Cancers Market Set to Register Immense Growth at a CAGR of 9.4% During the Study Period (2020-2034) | DelveInsight

New Study Data on Chemo-Immunotherapy Approach Using the ELIAS Cancer Immunotherapy (ECI®) to Treat Bone Cancer in Dogs Demonstrates Improved Outcomes

RWJBarnabas Health, Rutgers Cancer Institute, Tufts Medical Center, and The University of Manchester Develop First Risk Prediction Model for Early-Stage Classic Hodgkin's Lymphoma

Zemcelpro® (UM171 Cell Therapy) receives positive CHMP opinion for treatment of blood cancer patients without access to suitable donor cells

Japan's Top Eczema App, Atopiyo, Launches in the US: Pioneering Digital Eczema Care

Dizal Completes Enrollment for its Phase III Pivotal Study of Sunvozertinib vs. Platinum Doublet in Treatment Naïve NSCLC Patients with EGFR Exon20 Insertional Mutations

Immuno Cure and PharmaJet Announce Collaboration to Advance a Novel HIV Therapeutic DNA Vaccine Using Needle-Free Technology in Humans

Simcere Zaiming Announces First Patient Dosed in the US in a Phase 1 Trial of Trispecific Antibody SIM0500 in Patients with Relapsed/Refractory Multiple Myeloma

Osteoarthritis Market is Predicted to Exhibit Remarkable Growth During the Forecast Period (2025-2034) | DelveInsight

From Ancestry Entertainment to Real Health: Why 23andMe Failed and HoliVita Delivers

Are You Eligible for a Government Health Scheme? A Checklist You Can Use Today

Camurus' POSITANO study shows treatment effects with CAM2029 in polycystic liver disease patients

Oncoinvent Announces Positive Final Data from Phase 1/2a Trial of Radspherin® in Patients with Colorectal Peritoneal Metastases

Ascletis Announces First Participants Dosed in U.S. Phase I Clinical Study of ASC50, a Potential Best-in-Class Oral Small Molecule IL-17 Inhibitor for the Treatment of Psoriasis

Medindia Newsletters